Contact Us

OUR EXPANDED ACCESS POLICY (EAP) TO INVESTIGATIONAL DRUGS

• Tempest understands that there are times when an individual is unable to participate in a clinical trial, and other treatment options have been exhausted. In those cases, the individual's physician may choose to request access to an investigational drug outside of a clinical trial via what is often termed “Expanded Access” in the United States.
• At this time, participation in a clinical trial is the only way to gain access to Tempest’s investigational therapies. As more clinical data on the safety and efficacy of these investigational therapies become available, Tempest may review and update this policy on Expanded Access.